Prospective Study of Radial Artery Occlusion Following Transradial Arterial Access during Interventional Radiology Procedures

Author(s):  
Clark R. Restrepo ◽  
Nora E. Tabori ◽  
Saher S. Sabri ◽  
Keith M. Horton ◽  
Gajan Sivananthan
2019 ◽  
Vol 30 (11) ◽  
pp. 1832-1839 ◽  
Author(s):  
Dirk J. van der Heijden ◽  
Maarten A.H. van Leeuwen ◽  
Marco J.P.F. Ritt ◽  
Matti M.L. Dapper ◽  
Karin Boer ◽  
...  

2021 ◽  
Vol 14 (10) ◽  
pp. 1160-1161
Author(s):  
Adel Aminian ◽  
Maarten A.H. van Leeuwen ◽  
Juan F. Iglesias

2019 ◽  
Vol 71 (1) ◽  
Author(s):  
Mohamed A. Sadaka ◽  
Waleed Etman ◽  
Walid Ahmed ◽  
Saeed Kandil ◽  
Salah Eltahan

2017 ◽  
Vol 10 (1) ◽  
pp. 103
Author(s):  
Michael Koutouzis ◽  
Christos Maniotis ◽  
Grigorios Avdikos

2021 ◽  
Vol Publish Ahead of Print ◽  
Author(s):  
Surya Dharma ◽  
William Kamarullah ◽  
Nurcahyani ◽  
Rachmatu Bill Multazam ◽  
Claudia Mary Josephine

2021 ◽  
Author(s):  
Matthaios Didagelos ◽  
Areti Pagiantza ◽  
Thomas Zegkos ◽  
Christos Papanastasiou ◽  
Konstantina Zarra ◽  
...  

Radial artery occlusion (RAO) is the commonest complication of transradial catheterization. There is no evidence-based therapy, in the frame of a randomized control study, for the treatment of RAO. The purpose of the LOW-RAO study is to question the hypothesis if low-molecular-weight heparin is effective in the treatment of RAO after transradial coronary catheterization (both angiography and percutaneous coronary intervention). It is a prospective, open label, randomized controlled trial that will randomize 60 patients with RAO, irrespective of symptoms, into two groups, one receiving anticoagulation with low-molecular-weight heparin and the other receiving no treatment. The primary end point is improvement in radial artery patency rate at 4 weeks after the procedure. Trial registration number: NCT04196309 (ClinicalTrials.gov)


Sign in / Sign up

Export Citation Format

Share Document